RhumbLine Advisers’s Dr. Reddy's Laboratories RDY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.53M | Buy |
367,799
+24,510
| +7% | +$368K | ﹤0.01% | 1353 |
|
|
2025
Q1 | $4.53M | Sell |
343,289
-86,773
| -20% | -$1.14M | ﹤0.01% | 1409 |
|
|
2024
Q4 | $6.79M | Buy |
430,062
+44,722
| +12% | +$706K | 0.01% | 1257 |
|
|
2024
Q3 | $6.12M | Buy |
385,340
+7,125
| +2% | +$113K | 0.01% | 1319 |
|
|
2024
Q2 | $5.76M | Sell |
378,215
-93,910
| -20% | -$1.43M | 0.01% | 1311 |
|
|
2024
Q1 | $6.93M | Sell |
472,125
-6,410
| -1% | -$94K | 0.01% | 1244 |
|
|
2023
Q4 | $6.66M | Buy |
478,535
+31,620
| +7% | +$440K | 0.01% | 1258 |
|
|
2023
Q3 | $5.98M | Buy |
446,915
+2,185
| +0.5% | +$29.2K | 0.01% | 1248 |
|
|
2023
Q2 | $5.61M | Buy |
+444,730
| New | +$5.61M | 0.01% | 1307 |
|
|
2013
Q3 | – | Sell |
-301,500
| Closed | -$2.28M | – | 2987 |
|
|
2013
Q2 | $2.28M | Buy |
+301,500
| New | +$2.28M | 0.01% | 1217 |
|